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OBJECTIVE: The native aortic valve can be explained with rules of the 
equal side triangle. In pathologic condition, because of the flow influ­
ence there is a distortion on such a way that every aortic valve leaflet is 
different size. Mostly in the cases non coronaria leaflet is the biggest one 
because the spirals flow of the blood. With this study we evaluated clin­
ica results of stentless 3leaflets pericardial patch in patients undergoing 
aortic valve replacemen t 
METHODS: We created this stentless valve using bowine/equine pericar­
dium, replacing valve cusps on aortic fibrous ring of patient. This valve 
was made from same pericardium from which other biologic valve pros­
thesis are done. Our aortic valve is called really stentlless, because the 
new created leaflets are directly sutured on the patient's native aortic 
ring The ring of patient's aorta was used as guide for sizing this valve. 
Leaflets are implanted separately; using continuous sutures with 2 sup­
ported stitches at newly created commisurae,without a stent or sowing 
ring. Patients with aortic valvular stenosis have been included. Exclud­
ing criteria were postenotic aneurysmatically changes of the ascending 
aorta as well as aortic anuly ring dilatation I ntraoperative and postoper ­
ative TEE was performed for every created valve. 
RESULTS: 42 pts with aortic valvular disease had been included in study. 
2Iaf them got bowine and 21 equine perivardium created leaflets. Middle 
aorta cross clamping time was 71.94 min, and bypass time 112.33 min. 
t! patients got a aortocoronary bypass in combination (2.3 grafts per pts) 
1 patient developed middle aortic regitation. Mortality rate was 9.5% 
(4 pts). Follow up period 1-19 months. 
CONCLUSIONS: Real stentless aortic valve bio prosthesis ensures hae­
modynamic improvement with a small transvalvular gradient in pts.lt 
can be implanted even in patients with small root or with bicuspid valve, 
with good clinical outcome. 
